Cargando…

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients(§)

BACKGROUND: Little is known about the potential of statin-induced high-density lipoprotein cholesterol (HDL-C) increase to improve renal function in coronary heart disease (CHD) patients. METHODS AND RESULTS: In thispost hocanalysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Athyros, Vasilios G, Kakafika, Anna I, Papageorgiou, Athanasios A, Pagourelias, Efstathios D, Savvatianos, Savvas D, Elisaf, Moses, Karagiannis, Asterios, Tziomalos, Konstantinos, Mikhailidis, Dimitri P
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd 2007
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570568/ https://www.ncbi.nlm.nih.gov/pubmed/18949085 http://dx.doi.org/10.2174/1874192400701010008

Ejemplares similares

Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study
por: Athyros, Vasilios G., et al.
Publicado: (2013)

Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment
por: Athyros, Vasilios G, et al.
Publicado: (2011)

IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases
por: Tziomalos, Konstantinos, et al.
Publicado: (2011)

Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?
por: Athyros, Vasilios G, et al.
Publicado: (2011)

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
por: Athyros, Vassilios G., et al.
Publicado: (2011)

Off target effects of statins shape total mortality?
por: Athyros, Vasilios G., et al.
Publicado: (2016)

Is There a Role for Hypolipidaemic Drug Therapy in the Prevention or Treatment of Microvascular Complications of Diabetes?
por: Mitsiou, Eydoxia K, et al.
Publicado: (2012)

The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings
por: Athyros, Vasilios G., et al.
Publicado: (2012)

Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action
por: Athyros, Vasilios Gabriel, et al.
Publicado: (2016)

Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?
por: Katsiki, Niki, et al.
Publicado: (2013)

Implementation of Guidelines for the Management of Arterial Hypertension. The Impulsion Study
por: Karagiannis, Asterios, et al.
Publicado: (2009)

Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review
por: Tziomalos, Konstantinos, et al.
Publicado: (2006)

Are we getting to lipid targets in real life?
por: Katsiki, Niki, et al.
Publicado: (2010)

Patient with Hypertriglyceridemia, Type 2 Diabetes, and Chronic Kidney Disease Treated with Atorvastatin and Omega-3 Fatty Acid Ethyl Esters
por: Athyros, Vasilios G, et al.
Publicado: (2012)

Is There an Association Between Carotid-Femoral Pulse Wave Velocity and Coronary Heart Disease in Patients with Coronary Artery Disease: A Pilot Study
por: Katsiki, Niki, et al.
Publicado: (2016)

Ear lobe crease: a marker of coronary artery disease?
por: Agouridis, Aris P., et al.
Publicado: (2015)

The Role of Statins in the Management of Patients Undergoing Coronary Artery Bypass Grafting
por: Siskos, Dimitrios, et al.
Publicado: (2018)

Low HDL Cholesterol, Smoking and IL-13 R130Q Polymorphism are Associated with Myocardial Infarction in Greek Cypriot Males. A Pilot Study
por: Xenophontos, Stavroulla, et al.
Publicado: (2008)

Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study
por: Anagnostis, Panagiotis, et al.
Publicado: (2014)

Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes
por: Kostara, Christina E., et al.
Publicado: (2020)

Obstructive sleep apnoea syndrome and cardiovascular risk
por: Kostapanos, Michael S., et al.
Publicado: (2012)

Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study
por: Filippatos, Theodosios D., et al.
Publicado: (2013)

Exploring the Anthropometric, Cardiorespiratory, and Haematological Determinants of Marathon Performance
por: Christou, Georgios A., et al.
Publicado: (2021)

The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it
por: Xiong, Xiaowei, et al.
Publicado: (2015)

More Good News on Statins and COVID-19
por: Katsiki, Niki, et al.
Publicado: (2021)

Statin escape phenomenon: Fact or fiction?
por: Barkas, Fotios, et al.
Publicado: (2017)

Kidney Function and Estimated Vascular Risk in Patients with Primary Dyslipidemia
por: Tziomalos, Konstantinos, et al.
Publicado: (2009)

The vital need for Allergy Training: removing the doubts
por: Papadopoulos, Nikolaos G, et al.
Publicado: (2013)

Are Patients with Low Non-HDL Cholesterol “Non-responders” to Statin Therapy on Coronary Plaque Regression?
por: Koba, Shinji
Publicado: (2016)

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
por: Moutzouri, Elisavet, et al.
Publicado: (2010)

Reduced Serum Vitamin D Levels Are Associated with Insulin Resistance in Patients with Obstructive Sleep Apnea Syndrome
por: Archontogeorgis, Kostas, et al.
Publicado: (2019)

A Left Atrial Appendage Phantom Structure
por: Papadopoulos, Christodoulos E., et al.
Publicado: (2016)

Suboptimal management of dyslipidemia in everyday clinical practice: Alarming signals from real-world data
por: Athyros, Vasilios G., et al.
Publicado: (2020)

Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study
por: Kei, Anastazia, et al.
Publicado: (2011)

Evaluation of myocardial function in pediatric patients with the transposition of great arteries after arterial switch operation
por: Pagourelias, Efstathios D., et al.
Publicado: (2016)

Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease
por: Hoursalas, Athanasios, et al.
Publicado: (2022)

Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate
por: Hobbs, FD Richard, et al.
Publicado: (2016)

Prevalence of statin intolerance: a meta-analysis( )
por: Bytyçi, Ibadete, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tbnhqbkk2f23fdiebte8l7g6tl